Gordon Price, MD
Plastic Surgery · Chevy Chase, MDNPI 1245371954
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 75.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $257 and has fallen 77.3% since, to $58 in 2024. That places this record below the midpoint for plastic surgery clinicians in MD, where the typical reported total is $1,838.
Across 46 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$743
- Stryker$93
- Integra Lifesciences Corporation$45
- Mentor Worldwide LLC$40
- Smith+Nephew$38
- Tepha Inc$25
What the payments were for
- Food & beverage$984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $743 |
| Stryker | 1 | $93 |
| Integra Lifesciences Corporation | 2 | $45 |
| Mentor Worldwide LLC | 2 | $40 |
| Smith+Nephew | 2 | $38 |
| Tepha Inc | 1 | $25 |
How this compares
$984 in reported general payments places this provider in the 30th percentile of 105 plastic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $172 |
| Ondansetron OdtOndansetron | 30 | $126 |
| Cephalexin | 23 | $88 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Chevy Chase
- Samir RaoChevy Chase$26K
- Frank AlbinoChevy Chase$25K
- Navin SinghChevy Chase$16K
- Ornela KutzkeChevy Chase$5K
- James BrunoChevy Chase$5K
- Christopher BrownChevy Chase$4K
- Sheilah LynchChevy Chase$2K
- Wendell MilesChevy Chase$2K
- Chad GordonBaltimore$2.9M
- Larry LicksteinTowson$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.